Michael W Malafronte bought $3.6M of Covista (CVSA)
Executed Mar 10, disclosed Mar 12, 2 days later.
Over the 21 trading sessions from the disclosed entry session (Mar 12), the stock returned +9.9% (delay-adjusted); from the execution session (Mar 10), +15.6%. Derived: entry at the session's open, exit at the close 20 sessions later.
Michael W Malafronte (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in Covista Inc. (CVSA). Across 2 priced purchase filings, the average 21-session return was +16.7% from execution and +13.7% from disclosure (delay-adjusted; derived). The largest single filing was $3.6M of CVSA (36,036 sh across 3 lots, as filed), executed Mar 10.
Consumer Defensive · Covista Inc., together with its subsidiaries, provides healthcare education in the United States, Barbados, St
More Consumer Defensive filings→ Insider filings, newest first→ View the original filing at www.sec.gov→1,200 sh × $97.97
Exec Mar 3
Filed Mar 5 · 4:31 PM ET